Inmune Stock Market Value

INMB
 Stock
  

USD 8.77  0.07  0.79%   

Inmune Bio's market value is the price at which a share of Inmune Bio stock trades on a public exchange. It measures the collective expectations of Inmune Bio investors about the entity's future performance. With this module, you can estimate the performance of a buy and hold strategy of Inmune Bio and determine expected loss or profit from investing in Inmune Bio over a given investment horizon. Please see Inmune Bio Hype Analysis, Inmune Bio Correlation, Inmune Bio Valuation, Inmune Bio Volatility, as well as analyze Inmune Bio Alpha and Beta and Inmune Bio Performance.
Symbol
Backtest


Is Inmune Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inmune Bio. If investors know Inmune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inmune Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
157.4 M
Quarterly Revenue Growth YOY
39.75
Return On Assets
-0.24
Return On Equity
-0.47
The market value of Inmune Bio is measured differently than its book value, which is the value of Inmune that is recorded on the company's balance sheet. Investors also form their own opinion of Inmune Bio's value that differs from its market value or its book value, called intrinsic value, which is Inmune Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inmune Bio's market value can be influenced by many factors that don't directly affect Inmune Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inmune Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine Inmune Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inmune Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Inmune Bio 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Inmune Bio's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Inmune Bio.
0.00
05/04/2022
No Change 0.00  0.0 
In 2 months and 2 days
07/03/2022
0.00
If you would invest  0.00  in Inmune Bio on May 4, 2022 and sell it all today you would earn a total of 0.00 from holding Inmune Bio or generate 0.0% return on investment in Inmune Bio over 60 days. Inmune Bio is related to or competes with 3M. INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patients innate i...More

Inmune Bio Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Inmune Bio's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Inmune Bio upside and downside potential and time the market with a certain degree of confidence.

Inmune Bio Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Inmune Bio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Inmune Bio's standard deviation. In reality, there are many statistical measures that can use Inmune Bio historical prices to predict the future Inmune Bio's volatility.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Inmune Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Inmune Bio in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
2.368.6915.02
Details
Intrinsic
Valuation
LowReal ValueHigh
7.8915.6321.96
Details
Naive
Forecast
LowNext ValueHigh
2.849.1615.49
Details
2 Analysts
Consensus
LowTarget PriceHigh
32.0037.0042.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Inmune Bio. Your research has to be compared to or analyzed against Inmune Bio's peers to derive any actionable benefits. When done correctly, Inmune Bio's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Inmune Bio.

Inmune Bio Backtested Returns

Inmune Bio appears to be somewhat reliable, given 3 months investment horizon. Inmune Bio holds Efficiency (Sharpe) Ratio of 0.0342, which attests that the entity had 0.0342% of return per unit of risk over the last 3 months. Our standpoint towards determining the volatility of a stock is to use all available market data together with stock-specific technical indicators that cannot be diversified away. We have found twenty-one technical indicators for Inmune Bio, which you can use to evaluate the future volatility of the firm. Please utilize Inmune Bio's Risk Adjusted Performance of 0.0483, market risk adjusted performance of 0.1108, and Downside Deviation of 6.13 to validate if our risk estimates are consistent with your expectations.
On a scale of 0 to 100, Inmune Bio holds a performance score of 2. The company retains a Market Volatility (i.e., Beta) of 1.6625, which attests to a somewhat significant risk relative to the market. Let's try to break down what Inmune's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Inmune Bio will likely underperform. Although it is important to respect Inmune Bio current price history, it is better to be realistic regarding the information on the equity's current price movements. The philosophy towards determining future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By evaluating Inmune Bio technical indicators, you can presently evaluate if the expected return of 0.22% will be sustainable into the future. Please utilizes Inmune Bio maximum drawdown, and the relationship between the information ratio and downside variance to make a quick decision on whether Inmune Bio current trending patterns will revert.

Auto-correlation

    
  -0.56  

Good reverse predictability

Inmune Bio has good reverse predictability. Overlapping area represents the amount of predictability between Inmune Bio time series from 4th of May 2022 to 3rd of June 2022 and 3rd of June 2022 to 3rd of July 2022. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Inmune Bio price movement. The serial correlation of -0.56 indicates that roughly 56.0% of current Inmune Bio price fluctuation can be explain by its past prices.
Correlation Coefficient-0.56
Spearman Rank Test-0.46
Residual Average0.0
Price Variance0.6

Inmune Bio lagged returns against current returns

Autocorrelation, which is Inmune Bio stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Inmune Bio's stock expected returns. We can calculate the autocorrelation of Inmune Bio returns to help us make a trade decision. For example, suppose you find that Inmune Bio stock has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the stock movement to match the lagging time series.
 Current and Lagged Values 
Share
      Timeline 

Inmune Bio regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Inmune Bio stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Inmune Bio stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Inmune Bio stock over time.
 Current vs Lagged Prices 
Share
      Timeline 

Inmune Bio Lagged Returns

When evaluating Inmune Bio's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Inmune Bio stock have on its future price. Inmune Bio autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Inmune Bio autocorrelation shows the relationship between Inmune Bio stock current value and its past values and can show if there is a momentum factor associated with investing in Inmune Bio.
 Regressed Prices 
Share
      Timeline 

Inmune Bio Investors Sentiment

The influence of Inmune Bio's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Inmune. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Inmune Bio Implied Volatility

    
  81.22  
Inmune Bio's implied volatility exposes the market's sentiment of Inmune Bio stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Inmune Bio's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Inmune Bio stock will not fluctuate a lot when Inmune Bio's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Inmune Bio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Inmune Bio's short interest history, or implied volatility extrapolated from Inmune Bio options trading.

Current Sentiment - INMB

Inmune Bio Investor Sentiment

Macroaxis portfolio users are indifferent in their judgment towards investing in Inmune Bio. What is your judgment towards investing in Inmune Bio? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Inmune Bio using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Inmune Bio Hype Analysis, Inmune Bio Correlation, Inmune Bio Valuation, Inmune Bio Volatility, as well as analyze Inmune Bio Alpha and Beta and Inmune Bio Performance. Note that the Inmune Bio information on this page should be used as a complementary analysis to other Inmune Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Complementary Tools for Inmune Stock analysis

When running Inmune Bio price analysis, check to measure Inmune Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inmune Bio is operating at the current time. Most of Inmune Bio's value examination focuses on studying past and present price action to predict the probability of Inmune Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Inmune Bio's price. Additionally, you may evaluate how the addition of Inmune Bio to your portfolios can decrease your overall portfolio volatility.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Inmune Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Inmune Bio technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Inmune Bio trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...